Document is current
Any future updates will be listed below
-
Authors
Kronenberg, Zev N. https://orcid.org/0000-0002-7627-9808
Rhie, Arang
Koren, Sergey https://orcid.org/0000-0002-1472-8962
Concepcion, Gregory T. https://orcid.org/0000-0001-5921-2022
Peluso, Paul
Munson, Katherine M. https://orcid.org/0000-0001-8413-6498
Porubsky, David
Kuhn, Kristen
Mueller, Kathryn A.
Low, Wai Yee https://orcid.org/0000-0002-0749-765X
Hiendleder, Stefan https://orcid.org/0000-0001-6222-3240
Fedrigo, Olivier
Liachko, Ivan
Hall, Richard J. https://orcid.org/0000-0001-6490-8227
Phillippy, Adam M. https://orcid.org/0000-0003-2983-8934
Eichler, Evan E.
Williams, John L. https://orcid.org/0000-0001-5188-7957
Smith, Timothy P. L. https://orcid.org/0000-0003-1611-6828
Jarvis, Erich D. https://orcid.org/0000-0001-8931-5049
Sullivan, Shawn T.
Kingan, Sarah B. https://orcid.org/0000-0002-4900-0189
- License Information
-
More Information
Article History
Received: 13 May 2020
Accepted: 12 November 2020
First Online: 28 April 2021
Competing interests
: E.E.E. is on the scientific advisory board (SAB) of DNAnexus, Inc. [and was an SAB member of Pacific Biosciences, Inc. (2009–2013)]. S.B.K., Z.N.K., P.P., G.T.C., and R.J.H. are employees and share holders of Pacific Biosciences, a company developing single-molecule sequencing technologies. S.T.S. and I.L. are employee and share holders, and Z.N.K. and K.A.M. are shareholder of Phase Genomics, a provider of services and products for Hi-C and other proximity-ligation methods. The remaining authors declare no competing interests.
